Seoul National University
Seoul National University
Explore linked clinical trials.14 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis in Chronic Obstructive Pulmonary Disease | Chronic Disease, Disease Attributes, Disease Progression, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, chronic obstructive pulmonary disease, disease, lung disorder, lung neoplasm, neoplasm, obstructive lung disease, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not stated | 2026-07-21 | NCT07712016 | |
| A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, rifampicin-resistant tuberculosis, tuberculosis | Not yet recruiting | Phase 3 | 2026-06-30 | NCT07675954 | |
| Effects of Postprandial Walking and Resistance Snacking on Glucose Responses in Adults With Metabolic Syndrome | Insulin Resistance, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, prediabetes syndrome | Not yet recruiting | Not applicable | 2026-06-02 | NCT07620886 | |
| Structured Peer-delivered ART and Reentry Community Strategy | Retention in Care | Recruiting | Not applicable | 2026-06-02 | NCT06027671 | |
| Refractory Breathlessness in COPD | Chronic Disease, Disease Attributes, Dyspnea, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Not stated | 2025-09-08 | NCT07160322 | |
| Impact of the Korea Early Childhood Home-visiting Intervention | Child Development; Infant Development; Maternal Distress; Parenting; Pregnancy Related | Active, not recruiting | Not applicable | 2025-07-16 | NCT04749888 | |
| OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 4 | 2025-05-22 | NCT05333328 | |
| Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Active, not recruiting | Not stated | 2025-05-15 | NCT05756699 | |
| Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients | Inflammation, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Enrolling by invitation | Not stated | 2025-03-12 | NCT06447532 | |
| Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not stated | 2024-12-27 | NCT06751108 | |
| Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe) | Drug Labelling; Medication Management; Mobile Health | Recruiting | Not applicable | 2024-11-27 | NCT06703697 | |
| Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Recruiting | Not applicable | 2024-11-07 | NCT06618638 | |
| Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 2 | 2024-07-03 | NCT06138769 | |
| Thoracic Sympathetic Ganglion Block With Botulinum Toxin Type A | autonomic nervous system disorder, complex regional pain syndrome, nervous system disorder, neuromuscular disease, peripheral nervous system disorder | Not yet recruiting | Not applicable | 2024-06-26 | NCT06470581 |